Results from Phase 1/2 Study of Kelun-Biotech’s TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies, Published in Journal of Hematology & Oncology

Last Updated On June 11, 2025

Get Up to 20% OFF

News

‘I’d hoped to capture the graphic chaos in the window. What I found was an even more tangled scene’: Michael Krupka’s best phone picture

Dissatisfaction with life in UK unchanged since Covid, official data shows

‘Watching my six year old deadlift 35kg was pretty cool’: meet the children who work out

I am in my 30s, unmarried, and afraid I’ve missed my chance. How do I make peace with my fear? | Leading questions

NHS maternity units often cover up harmful errors in childbirth, report finds

What is the national maternity and neonatal investigation and why was it launched?

2025-06-10 – Press Releases – www.prnewswire.com

CHENGDU, China, June 10, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) today announced that results from the Phase 1/2 study (KL264-01/MK-2870-001) evaluating the novel TROP2 antibody drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) as…

Read the full article here.

Get Up to 20% OFF

Related Feeds

Being labelled a Highly Sensitive Person was validating and empowering – until it wasn’t | Miranda Luby

12 one-legged yoga poses you must do to improve balance and flexibility

Angelalign Technology Announces First-Half 2025 Results While Increasing Investments in Legal, Supply Chain and Data Security

‘I still want to achieve’: people living with stage 4 cancer embrace Chris Hoy charity ride

Boom in fitness events as gym-goers seek out connection and competition

LabConnect and OmniScience to Deliver First Agentic AI Solution for Real-Time Clinical Trial Lab Insights

LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased

NHS manager ordered to stop selling ‘sleep drug-laced’ children’s gummies

7 surprising benefits of wall squats and how to do them properly

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

Telix Completes Acquisition of RLS (USA) Inc.

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

Turtlebrace is now available through SPS and at Hanger Clinics Across the U.S.

Chulalongkorn University Unveils AnthoRice Complex, A Breakthrough in Hair-Root Science

Therapy isn’t about life hacks. The best solutions are simpler – and more complex

Feihe Captivates at the 28th Harvard China Forum, Earning the Trust of North American Consumers with Its Products

COMPANY

Mon-Fri 10 am to 7 pm.

Warehouse: (No Walk-In)

Scommerce, 1 Buroh Crescent #03-01
Cogent 1.Logistics Hub S(627545)

Qxpress, 30 Tuas West Rd, level 5, S (638386)

Wellness

Can a Multivitamin Really Optimize Men’s Health? The Science Behind Essential Nutrients

Wellness

15 minute FULL BODY HIIT Workout // No Equipment

Wellness

What Are the Signs You Need a Body Detox?

Beauty

Tired of Reapplying Moisturizer? This Hydrate Serum Holds the Key to 72-Hour Dewy Skin

Beauty

2025’s Essential Guide to Face Sunscreens: Daily SPF Heroes with Blue Light Defense

Beauty

Best Hair Tonic for Hair Growth – Comprehensive Guide for 2025

All the content on this website, including medical opinion and any other health-related information, are solely to provide information only. Any information/statements on this blog are not intended to diagnose, treat, cure or prevent any disease, and should NOT be a substitute for health and medical advice that can be provided by your own physician/medical doctor. You should always consult a doctor before making any health or diet changes, especially any changes related to a specific diagnosis or condition.